Lysine Residue 114 in Human Antithrombin III Is Required for Heparin Pentasaccharide-mediated Activation
Open Access
- 21 March 1997
- journal article
- Published by Elsevier
- Vol. 272 (12) , 7656-7660
- https://doi.org/10.1074/jbc.272.12.7656
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Heparin binding domain of antithrombin III: characterization using a synthetic peptide directed polyclonal antibodyBiochemistry, 1990
- Antithrombin Rouen‐IV 24 Arg→Cys The amino‐terminal contribution to heparin bindingFEBS Letters, 1990
- Antithrombin III alger: A new case of Arg 47 ← cys mutationAmerican Journal of Hematology, 1987
- Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisBlood, 1987
- Antithrombin III and its interaction with heparin. Comparison of the human, bovine and porcine proteins by proton NMR spectroscopyBiochemistry, 1987
- Molecular characterization of the antithrombin III tours deficiencyThrombosis Research, 1987
- Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.Proceedings of the National Academy of Sciences, 1984
- Circular dichroism spectroscopy of heparin-antithrombin interactionsProceedings of the National Academy of Sciences, 1982
- The molecular-weight-dependence of the anti-coagulant activity of heparinBiochemical Journal, 1978
- The Binding of Low-Affinity and High-Affinity Heparin to Antithrombin. Fluorescence StudiesEuropean Journal of Biochemistry, 1978